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Abstract 
Background: Extended-spectrum cephalosporin-resistant organisms are the 
sources of AmpC- type β-lactamase isolates. AmpC-producing Klebsiella 
pneumoniae isolates are a major challenge in clinics due to their high rate of 
antibiotic resistance. This study aimed to detect AmpC β-lactamases in K. 
pneumoniae isolated from hospitalized patients with a surgical history.  
Materials and Methods: This cross-sectional study was performed on 120 
urine catheter samples. After antibiotic susceptibility testing, plasmid-mediated 
AmpC was detected by double-disc plus combined disc test (DCDT) and three-
dimensional extract test (TDET). The genotypic detection of plasmid-mediated 
AmpC was carried out using multiplex-polymerase chain reaction (PCR).  
Results: Of 120 samples, 60 (50%) instances of K. pneumoniae were 
isolated. The highest and lowest resistance rates were related to cefotaxime 
(CTX) (50%) and ciprofloxacin (CIP) (23.3%), respectively. 18.3% (n: 11) 
K. pneumoniae showed an AmpC phenotype in DCDT and TDET tests. 
AmpC genotyping showed that the prevalence of CIT, DHA, EBC, and ACC 
genotypes were 47.1%, 35.3%, 29.5%, and 23.6%, respectively. MOX and 
FOX genotypes were not identified in the isolates of interest.  
Conclusion: AmpC β-lactamase identification tests should be considered a 
routine microbiology workup for gram-negative microorganisms. Multiplex-
PCR can identify the plasmid AmpC genotypes.  
Keywords: AmpC, Klebsiella pneumoniae, Double-disc plus combined test, 
Three-dimensional extract test 
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Perioperative hospital infection is a serious medical 
challenge with a difficult and sophisticated 
management process. Bacterial agents can affect 
patients’ treatment process and hospitalization time 
(1). Several bacterial agents can cause hospital 
infections; among them, Klebsiella pneumoniae, a rod-
shaped gram-negative bacterium, is a common cause 
(2-4). Treatment of infections caused by drug-resistant 
K. pneumoniae is a major challenge because of its 
intrinsic and acquired resistance to a broad spectrum of 
antimicrobials (4). The main mechanism for resistance 
to β-lactam-class antibiotics is synthesizing b-
lactamases, one of the most important beings AmpC 
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(5). This enzyme confers resistance to most β-lactam 
drugs except cefepime and carbapenems. AmpC β-
lactamases are efficient at destroying penicillins, 
cephalosporins, and, in particular, cephamycins (6). 
According to the Ambler structural and Bush 
functional classifications, AmpC enzymes belong to 
class C and group III, respectively (7). AmpC-
encoding genes are located on both the chromosome 
and the plasmid. AmpC plasmid-encoded genes 
originate in the chromosome and can carry resistance 
genes against such antibiotics as aminoglycosides, 
quinolones, chloramphenicol, tetracycline, 
trimethoprim, and other categories of β-lactamases (8). 
Multidrug-Resistant-K (MDR-K) pneumoniae isolates 
that produce AmpC-resistance elements have become 
a major challenge to human health. This study aims to 
determine the antibiotic resistance profile and 
frequency of AmpC β-lactamases in K. pneumoniae 




Patients and bacterial strains: This cross-sectional 
study was carried out in 2017, for the year, in three 
teaching hospitals in Zahedan City. The ethical 
committee approved the study of Islamic Azad 
University Kerman Branch University. In total, urine 
catheter 120 samples were gathered from hospitalized 
patients with a history of a recent operation. Samples 
were streaked on MacConkey agar (Merck Co., 
Germany), then incubated at 37°C for 24 hours. All 
colonies were identified as K. pneumoniae by standard 
microbiological and biochemical tests, e.g. oxidase, 
gram stain, citrate utilization, motility, urease 
production, Triple Sugar Iron agar (TSI), Methyl Red, 
and Vogue Proskauer (MR-VP), and Sulfur, Indole, 
Motility (SIM). The Analytical Profile Index (API) 
20E system (Analytab, Inc., New York) confirmed the 
identification. 
 
Antimicrobial susceptibility testing: The 
susceptibility profile was determined using Mueller-
Hinton Agar (Merck Co., Germany). The disc diffusion 
method, based on the Clinical and Laboratory 
Standards Institute recommendation, was used for 
some antibiotics including cefotaxime (CTX: 30μg), 
ceftazidime (CAZ: 30μg), ceftriaxone (CRO: 30μg), 
ciprofloxacin (CIP: 5μg), and cefpodoxime (CPD, 
10μg) (Mast, Merseyside, UK). Fresh cultures were 
used in formulating a microbial suspension. The 
opacity of each suspension was adjusted equivalent to 
a 0.5 McFarland standard. Zone diameters were 
recorded after incubation at 37ºC for 18-24 hours. The 
results were reported as resistant, intermediate, and 
susceptible. The standard strain of K. pneumoniae 
ATCC 1029 was used as quality control. 
 
Identification of plasmid-mediated AmpC 
production: A disc impregnated with cefoxitin (FOX, 
30 µg) and another disc plus clavulanic acid/ 
ceftazidime (CAZ/CLA) were included in double-disc 
plus combined discs (DCDT) identification of AmpC-
 
Table 1: Primer oligonucleotide sequencing used in this study. 
Target  Primer  Sequence (5'→3') Product size 
(base-pair)  
MOX Forward GCTGCTCAAGGAGCACAGGAT 385 
Reverse CACATTGACATAGGTGTGGTGC 
CIT Forward TGGCCAGAACTGACAGGCAAA 462 
Reverse TTTCTCCTGAACGTGGCTGGC 
DHA Forward AACTTTCACAGGTGTGCTGGGT 405 
Reverse CCGTACGCATACTGGCTTTGC 
ACC Forward AACAGCCTCAGCAGCCGGTTA 346 
Reverse TTCGCCGCAATCATCCCTAGC 
EBC Forward TCGGTAAAGCCGATGTTGCGG 302 
Reverse CTTCCACTGCGGCTGCCAGTT 
FOX Forward AACATGGGGTATCAGGGAGATG 412 
Reverse CAAAGCGCGTAACCGGATTGG 
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type enzymes. An empty disc moistened with sterile 
saline was inoculated with a few colonies of the test 
organisms, placed next to a 30μg FOX disc on a 
Mueller-Hinton agar plate previously impregnated 
with a lawn of Escherichia coli ATCC 25922, and 
incubated at 37ºC overnight. Indentation of the FOX 
inhibition zone was an indicator of AmpC β-lactamase 
production. AmpC production was also confirmed by 
a modified three-dimensional extract test (TDET) (9). 
The colonies from overnight bacterial cultures on the 
Mueller-Hinton agar were moved to a sterile 
microcentrifuge tube, accommodating 10-15 mg of 
bacterial wet weight per sample. The bacteria were 
suspended in peptone water and centrifuged at 3000 
rpm (Sigma 1-14 Microfuge, St. Louis, United States) 
for 15 minutes. Crude cell extracts were obtained using 
ten cycles of alternate freeze-thawing at -78ºC (dry 
ice/ethanol bath) and 37ºC. Linear slits 3 cm long were 
cut into plates inoculated with each test bacterium 
using a sterile scalpel blade, 3 mm away from a 30 µg 
FOX disc, in an external radial direction. About 40-
50μL of the prepared extract was loaded into each split, 
and the plates were kept upright for 5 to 10 minutes, 
followed by incubation at 37ºC for 24 hours. AmpC 
production was verified when clear inhibition zones 
around the FOX disk were merged (10). 
 
Polymerase chain reaction: AmpC-encoding genes 
were characterized via polymerase chain reaction 
(PCR). Template DNA was extracted from colonies 
grown overnight on the brain-heart infusion agar 
(Merck Co., Germany) plates provided by the QIAprep 
Spin miniprep kit (Qiagen, Hilden, Germany). This 
product is stored at -20ºC until required. The quality 
and concentration of the extracted genomic DNA were 
assessed by a Nanodrop spectrophotometer (ND-1000, 
Thermo Scientific, Wilmington, DE, USA). Genomic 
DNA with a concentration of 0.1 ng/µl was used as the 
template. Amplification reactions were carried out in a 
total volume of 25 μl, containing 0.8 µl of extracted 
DNA, 2.0µl of 10× PCR buffer, 1.2mmol/l MgCl2, 
0.6µl (each) of dATP, dGTP, dCTP, and dTTP, 0.7µl 
of each primer, 0.9µl of Taq DNA polymerase (5 U/µl) 
(Ampliqon, Odense, Denmark) and 18.1µl ddH2O 
(Table 1). The samples were amplified in a Techne TC-
512 thermocycler (Eppendorf, Hamburg, Germany), 
following initial denaturation at 94ºC for 5 minutes, 35 
cycles of denaturation for 35 seconds at 94ºC, 
annealing for 35 seconds at 56ºC and extension for 35 
minutes at 72ºC, with a final extension for 5 minutes at 
72ºC. The PCR product was subjected to 
electrophoresis in a 1.0% agarose gel, stained by safe 
stain (Sina Genes, Iran), and photographed under 
ultraviolet illumination (Bio-Rad, Hercules, CA, 
USA). 
 
Amplicon sequences: Sanger dideoxy chain 
termination technique in both directions was 
performed by an ABI3730XL DNA analyzer (Applied 
Biosystems, Foster City, CA, USA). Similarity 
searches for the nucleotide sequences were conducted 
by special software called the "BLAST algorithm" 
(available at http://www.ncbi.nlm.nih.gov/blast). 
 
Statistical data analysis: The data were analyzed 
using SPSS version 11.5 (SPSS Inc., Chicago, IL, 
USA). Pearson's chi‐square tests were used in this 
study. P<0.05 was considered statistically significant. 
 
Results 
Out of 120 samples, 60 (50%) containing K. 
pneumoniae were obtained. The mean patient age was 
48.00±1.60 years (ranging from 15 to 75 years). The 
 
 
Table 2: Antibiogram of clinical isolates of K. pneumoniae. 
Antibiotic S# I† R* 
Ciprofloxacin (CIP) 46 (76.6%) 0 (0%) 14 (23.3%) 
Cefotaxime (CTX) 23 (38.3%) 7 (11.7%) 30 (50%) 
Ceftriaxone (CRO) 27 (45%) 4 (6.6%) 27 (45%) 
Cefpodoxime (CPD) 25 (41.7%) 6 (10%) 29 (48.3%) 
Ceftazidime (CAZ) 31 (51.7%) 10 (16.6%) 19 (31.7%) 
                                        *Resistant, †Intermediate, #Susceptible 
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studied strains belonged to different age groups: 15-25, 
n: 8; 26-36, n: 17; 37-47, n: 22; 48-58, n: 11 and 59-
75, n: 2. Forty-six (76.6%) patients were female and 14 
(4.23%) patients were male. Table 2 shows that the 
majority of the isolates are resistant to CTX (50%), 
CPD (48.3%), CRO (45%), CAZ (31.7%), and CIP 
(23.3%).  
In this study, 11 isolates of K. pneumoniae 
(18.3%) showed an AmpC-type phenotype in both 
DCDT and TDET tests. The AmpC gene amplification 
test showed that the prevalence of CIT, DHA, EBC and 
ACC genotypes was 47.1% (n: 8), 35.3% (n: 6), 29.5% 
(n: 5) and 23.6% (n: 4), respectively. MOX and FOX 




Effective use of microbiology laboratories to identify 
and prevent the spread of resistant microbial pathogens 
reduces the need for medication (11). Infection control 
is beneficial for patients and reduces the mortality rate 
(12). If microbial pathogens are misidentified as 
resistant or susceptible in laboratory tests, it may result 
in patients receiving inappropriate medication and 
transmitting the bacteria to other patients (13). 
Therefore, identifying human bacterial pathogens with 
hidden antibiotic resistance is essential, and a useful 
assay is needed to identify resistance mechanisms. This 
detection can be done by different methods, including 
molecular and microbial detection methods. Each of 
these methods has its advantages and disadvantages, 
but they are reliable with relatively consistent results. 
Among molecular methods, M-PCR can be used as a 
rapid and reliable procedure for detecting several 
antibiotic resistance genes at the same time.  
Bacteria have used several mechanisms to 
protect against the harmful effects of antibiotics (14). 
They are stepping up the production of broad-spectrum 
β-lactamases to inactivate antibiotics, resulting in 
multi-drug-resistant infections that have spread rapidly 
worldwide since their discovery in 1980. The main 
mechanism used by gram-negative bacteria against β-
lactam antibiotics is β-lactamase production. This type 
of enzyme inactivates antibiotics by hydrolyzing the β-
lactam ring (15). New β-lactam antibiotics developed 
during the past two decades are specifically resistant to 
this function of β-lactamases. Despite this, new types 
of β-lactamases, such as extended-spectrum β-




Figure 1. Amplification of AmpC using multiplex-polymerase chain reaction (M-PCR) among the K. pneumoniae 
isolates. The CIT (462 bp), DHA (405 bp), EBC (302 bp), and ACC (346 bp) PCR products were amplified, while MOX 
and FOX genes were not detected. 
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continues to present serious health challenges (16). 
This study found that 50%, 48.3%, 45%, 31.7%, 
and 23.3% of isolates were resistant to cefotaxime, 
cefpodoxime, ceftriaxone, ceftazidime, and 
ciprofloxacin, respectively. Pourali Sheshblouki et al. 
reported that 62.2% of isolates were resistant to 
ceftazidime, 55.9% to cefoxitin, 33.3% to 
aminoglycosides (gentamicin and amikacin), and 
33.3% to ciprofloxacin (17). Al-Marzooq et al. 
reported 71% of strains as being resistant to 
ciprofloxacin (18). In this study, 17 isolates (28.4%) 
were identified as ESBLs. Behrooozi et al. in Tehran 
and Gafourian et al. in Ilam found ESBL production in 
K. pneumoniae at 12% and 59.2%, respectively.18 In 
Saudi Arabia, Shibl et al. reported ESBL production in 
K. pneumoniae at 65% (19). The reported prevalence 
of ESBL-production strains depends on some factors: 
the high use of antibiotics, variations in regional 
antibiotic use, prolonged hospitalization inwards such 
as internal medicine and ICU, use of contaminated 
medical devices such as venous and urine catheters, 
and the scale of nosocomial infections.  
Third-generation cephalosporins are 
overprescribed. Antibiotic resistance thus has 
increased in many cities in Iran. Mardaneh et al., 
isolating blood cultures of patients in Shiraz, found that 
21.5% of positive cultures belonged to 
Enterobacteriaceae (20). Among the family members, 
28% were Klebsiella spp., which ranked second after 
Escherichia coli. Polymyxin B, colistin, and imipenem 
were the most effective drugs against Klebsiella's 
positive ESBL strains. Rostamzad et al., in Isfahan, 
showed that 17 isolates (32.7%) had the CTX-M-15 
gene and nine isolates (17.3%) had the FOX gene.21 
These results parallel the results of the current study; 
our study does not show a significant decrease in 
resistance. Japoni-Nejad et al. reported that the 
frequency of the AmpC β-lactamase gene in Arak was 
19%. As in our study, the FOX gene was not detected 
in any of the isolates.22 While these statistics reflect 
AmpC resistance in Zahedan, they are representative 




Antibiotic resistance is relatively common in southeast 
Iran, and the molecular detection method is a reliable 
and rapid method for detecting this kind of bacteria. 
AmpC β-lactamase identification tests, particularly 
molecular methods, should be considered a routine 
microbiology workup for gram-negative 
microorganisms. Multiplex-PCR can be used as a rapid 
and reliable method for the identification of different 
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